Drug intelligence / Profile preview

NeoForm

Development stage
Unknown
Lead developer
GXI
Modality
Small Molecules
Administration
Oral
01

Overview

NeoForm is a brand name for metformin hydrochloride, a biguanide antihyperglycemic agent primarily used for the management of type 2 diabetes mellitus. It functions through several distinct mechanisms: it reduces hepatic glucose production by inhibiting gluconeogenesis and glycogenolysis, decreases the intestinal absorption of glucose, and improves peripheral insulin sensitivity by increasing glucose uptake and utilization in tissues. Manufactured by GXI and distributed by Metro Drug in the Philippines, NeoForm is typically available as a 500mg tablet. It is used as a first-line therapy, particularly in overweight patients, and can be administered as monotherapy or in combination with other antidiabetic agents when diet and exercise alone are insufficient for glycemic control.

Brand names
NeoForm
Other names
metformin hydrochloride
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)ND1 (Mitochondrial electron transport chain complex I)

Beyond the preview

Go deeper on NeoForm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeoForm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call